Crystal's Coder Hub🧬 ICD-10 CM R59.0 — Localized Enlarged Lymph Nodes
Billable Code Confirmed
ICD-10 CM R59.0 is a valid, billable 4-character ICD-10-CM code for FY2026. The code structure includes the category (R59) for enlarged lymph nodes and the fourth character (.0) specifying that the enlargement is localized. No additional characters are required.1
Non-Billable Parent Codes — Never Submit These
- ❌
R59— 3-character header (Category) — Missing specificity regarding whether the enlargement is localized, generalized, or unspecified.Always submit R59.0 (all 4 characters) when the provider documents enlarged lymph nodes confined to a single anatomic region (e.g., cervical, axillary, inguinal).
Clinical Context: Localized vs. Generalized
ICD-10 CM R59.0 captures lymph node enlargement restricted to a single regional basin. This is a critical distinction from R59.1 (generalized), which implies involvement of two or more non-contiguous lymph node regions (e.g., both cervical and inguinal) and often points toward systemic etiologies like autoimmune disease, HIV, or widespread malignancy. Documentation must explicitly state “localized” or specify a single region to support this code over R59.9.2
Code Classification
ICD-10 CM Diagnosis Code — wRVU, assistant payable, and global period fields are not applicable. See the CPT Procedural Crosswalk and ICD-10-PCS Crosswalk sections for procedural correlations.
🔍 Code Description
ICD-10 CM R59.0 classifies Localized enlarged lymph nodes. This code represents a clinical sign where lymph nodes in a specific, isolated anatomic region are palpably or radiographically enlarged beyond normal limits (typically >1 cm for most nodes, though epitrochlear >0.5 cm or inguinal >1.5 cm may apply).3
Clinically, localized lymphadenopathy is most frequently reactive, stemming from a regional infection (e.g., streptococcal pharyngitis causing cervical adenopathy) or local inflammation. However, it can also be the initial presentation of regional malignancy, such as head and neck squamous cell carcinoma metastasis or localized lymphoma, necessitating further diagnostic workup including imaging and tissue biopsy.
🌳 Code Tree / Hierarchy
R59 Enlarged lymph nodes ❌ Non-billable
│
├── R59.0 Localized enlarged lymph nodes ◀ THIS CODE ✅ Billable
│
├── R59.1 Generalized enlarged lymph nodes ✅ Billable
│
└── R59.9 Enlarged lymph nodes, unspecified ✅ Billable
Specificity in Lymphatic Disorders
Payers and CDI specialists scrutinize the use of R59.9 versus specific codes. Using R59.0 demonstrates that the provider has evaluated the patient and confirmed the enlargement is not systemic. If the physical exam or imaging clearly identifies only one involved nodal basin, R59.0 is the most accurate code and supports medical necessity for targeted biopsies.4
✅ Includes
The following clinical terms and scenarios map to R59.0 when documented:
- Localized lymphadenopathy
- Regional lymphadenopathy
- Swollen lymph nodes confined to a single anatomic region
- Enlarged lymph nodes NOS of a single site (e.g., “enlarged left axillary lymph node”)
❌ Excludes
Excludes 1 — Cannot Be Coded Simultaneously with R59.0
| Code | Description | Note |
|---|---|---|
| B27.90 | Infectious mononucleosis, unspecified | If the localized lymphadenopathy is explicitly due to infectious mononucleosis, code the definitive infection. The symptom is integral to the disease. |
| B20 | Human immunodeficiency virus [HIV] disease | Persistent generalized lymphadenopathy is a hallmark of HIV; if the patient has HIV and lymphadenopathy, code B20. |
Excludes 1 Violation Risk
A common error is coding R59.0 alongside a definitive infectious or neoplastic diagnosis when the lymphadenopathy is a routine manifestation of that disease. Under UHDDS guidelines, do not code the symptom additionally if it is inherently part of the definitive diagnosis, unless the provider explicitly links it as a distinct, reportable condition.
Excludes 2 — May Be Coded in Addition if Separately Present
| Code | Description | Note |
|---|---|---|
| I88.9 | Nonspecific lymphadenitis (acute) (chronic) | Lymphadenitis implies active inflammation/infection of the node itself (often tender, erythematous), whereas lymphadenopathy (R59.0) is simply enlargement. If both distinct clinical entities are present in different regions, both may be coded. |
| R59.1 | Generalized enlarged lymph nodes | Mutually exclusive in the same region, but if a patient has localized enlargement in one area and generalized in others (rare documentation scenario), clarify with the provider. |
📋 Clinical Overview
Localized vs. Generalized Lymphadenopathy
The distinction between localized and generalized lymphadenopathy drives the diagnostic algorithm and determines the urgency of oncologic versus infectious workup.
| Feature | R59.0 — Localized | R59.1 — Generalized | R59.9 — Unspecified |
|---|---|---|---|
| Anatomic Involvement | Single regional basin (e.g., unilateral cervical) | ≥2 non-contiguous regions (e.g., cervical + inguinal) | Not specified in documentation |
| Common Etiologies | Local infection, regional metastasis, localized lymphoma | Systemic infection (HIV, EBV), autoimmune (SLE), systemic lymphoma/leukemia | Requires further H&P or imaging to classify |
| Initial Workup | Targeted US/CT of specific region, FNA/core biopsy | Systemic labs (CBC, HIV, ANA, flow cytometry), CT chest/abd/pelvis | Broad workup; often prompts CDI query |
CDI Query Trigger — Vague Documentation
If a provider documents “lymphadenopathy” without specifying “localized” or “generalized,” and the physical exam or radiology report clearly describes involvement of only one nodal basin (e.g., “multiple enlarged left axillary nodes”), a CDI query should be sent to clarify whether the condition is localized (R59.0) or generalized (R59.1) to avoid defaulting to R59.9.
Manifestations & Symptom Burden
- Palpable mass: Patient or provider notes a discrete, often mobile or fixed lump in the neck, axilla, or groin.
- Regional pain/tenderness: Suggests an acute inflammatory or infectious etiology (reactive node).
- Overlying skin changes: Erythema or warmth may indicate suppurative lymphadenitis rather than simple enlargement.
Coding Manifestations
Always code the documented manifestations to fully capture the patient’s complexity. Examples include:
💰 HCC Risk Adjustment (CMS-HCC v28)
| Field | Detail |
|---|---|
| CMS-HCC Model Version | v28 (2024-2025 Implementation) |
| HCC Assignment | ❌ Not HCC-Mapped |
| HCC Category | N/A |
| RAF Coefficient | N/A |
R59.0 does not map to an HCC under v28.
Capture Annually
While R59.0 itself is not HCC-mapped, the underlying etiology discovered during workup (e.g., Non-Hodgkin Lymphoma C85.9, HIV B20, or metastatic solid tumors) often is. Ensure the definitive diagnosis is captured annually once established to maximize RAF score accuracy and reflect true resource utilization.
🏥 MS-DRG Assignment
MDC 16 — Diseases and Disorders of the Blood and Blood Forming Organs and Immunological Disorders
| DRG | Title | Est. Relative Weight* |
|---|---|---|
| DRG 841 | Other Disorders of Blood and Blood Forming Organs with MCC | ~1.45 |
| DRG 842 | Other Disorders of Blood and Blood Forming Organs with CC | ~0.85 |
| DRG 843 | Other Disorders of Blood and Blood Forming Organs without CC/MCC | ~0.55 |
Approximate. Verify against IPPS FY2026 Final Rule tables.
Sequencing and Complications
R59.0 is rarely a principal diagnosis for inpatient admission unless the patient is admitted solely for an excisional biopsy of a deep node where outpatient workup was inconclusive. It typically sequences secondary to the underlying cause (e.g., C81.50 Nodular lymphocyte predominant Hodgkin lymphoma). It does not act as a CC/MCC, but associated complications like severe neutropenia (D70.9) or systemic inflammatory response (R65.10) do.
🔗 Related ICD-10-CM Codes
Specificity Variants
| Code | Description |
|---|---|
| R59.0 | Localized enlarged lymph nodes ← This Code |
| R59.1 | Generalized enlarged lymph nodes |
| R59.9 | Enlarged lymph nodes, unspecified |
Inflammatory/Infectious Variants
| Code | Description |
|---|---|
| I88.9 | Nonspecific lymphadenitis (acute) (chronic) |
| I88.0 | Nonspecific mesenteric lymphadenitis |
| B91 | Sequelae of unspecified lymphadenitis |
🛠️ Commonly Associated CPT Codes (Hematology / Oncology / Surgery)
Outpatient and Profee Setting Context
Documentation of R59.0 supports the medical necessity for diagnostic imaging and tissue sampling of the affected nodal basin. Ensure the diagnosis code is linked to the appropriate CPT line item on the claim.
| CPT Code | Description | Profee Coding Notes (Modifier 26) |
|---|---|---|
| 38500 | Biopsy or excision of lymph node; open, superficial | Used for open excisional biopsy of palpable nodes. |
| 38505 | Biopsy or excision of lymph node; by needle, superficial | Core needle or FNA of superficial node; US guidance separately reportable. |
| 38510 | Biopsy or excision of lymph node; open, deep cervical node | Used for deeper nodes requiring surgical dissection. |
| 76942 | Ultrasonic guidance for needle biopsy | Add-on code for imaging guidance during 38505 or 10005. |
NCCI Bundling Considerations
- 76942 (Ultrasound guidance) billed on the same day as 38505 (Needle biopsy of superficial lymph node) is generally separately reportable, as the primary code does not include imaging guidance. Ensure documentation supports the medical necessity for real-time guidance.
🔬 ICD-10-PCS Crosswalk (Inpatient Procedures)
When R59.0 is an inpatient diagnosis, these PCS codes are relevant for associated inpatient procedures.
| PCS Section | Body System | Root Operation | Clinical Application |
|---|---|---|---|
| 0 (Medical/Surgical) | 7 (Lymphatic and Hemic) | Excision | Excisional biopsy of a localized lymph node for definitive pathologic diagnosis, e.g., 07B63ZX (Cervical, Percutaneous). |
| 0 (Medical/Surgical) | 7 (Lymphatic and Hemic) | Extirpation | Incision and drainage of a suppurative localized lymph node (abscess), e.g., 07C60ZZ (Cervical, Open). |
💊 Coding Scenarios and Examples
Scenario 1 — Outpatient: Neck Mass Workup
Clinical Vignette: A 45-year-old male presents to the ENT clinic with a 3-week history of a painless lump in the right side of his neck. Physical exam reveals a 2.5 cm firm, mobile right cervical lymph node. No other lymphadenopathy is noted. An ultrasound-guided core needle biopsy is performed in the office.
CPT / HCPCS (Profee):
- 38505 — Biopsy or excision of lymph node; by needle, superficial
- 76942 — Ultrasonic guidance for needle biopsy
ICD-10-CM:
- R59.0 — Localized enlarged lymph nodes (specific documentation of single right cervical node)
Scenario 2 — Inpatient: Sequencing with Definitive Diagnosis
Clinical Vignette: A 62-year-old female is admitted for an excisional biopsy of an enlarged left axillary lymph node. Preoperative diagnosis is “left axillary lymphadenopathy.” Final pathology confirms metastatic invasive ductal carcinoma of the breast, originating from a previously undocumented primary breast lesion.
Principal Diagnosis:
- C50.912 — Malignant neoplasm of unspecified site of left female breast (Definitive diagnosis established during stay)
Secondary Diagnoses:
- C77.3 — Secondary and unspecified malignant neoplasm of axillary and upper limb lymph nodes (Metastatic spread)
- Note: R59.0 is NOT coded here, as the lymph node enlargement is an integral manifestation of the definitive metastatic neoplasm.
MS-DRG Assignment: Groups to MDC 09 (Diseases of the Skin/Subcutaneous Tissue and Breast) based on the principal diagnosis of breast malignancy, not MDC 16.
Scenario 3 — CDI Query: Clarifying Localized vs. Generalized
Clinical Vignette: The admission note states “patient presents with lymphadenopathy.” The physical exam documents “palpable 2 cm left inguinal lymph node.” The CT abdomen/pelvis report notes “mildly prominent bilateral inguinal lymph nodes, likely reactive, no other adenopathy.”
Action / Outcome: The coder identifies a discrepancy between the vague HPI (“lymphadenopathy”) and the specific imaging/exam findings (bilateral inguinal). A CDI query is sent to clarify if the lymphadenopathy is localized (inguinal region only) or generalized.
Query Response: Provider updates documentation to confirm: “Localized bilateral inguinal lymphadenopathy.”
Corrected ICD-10-CM Coding:
- R59.0 — Localized enlarged lymph nodes (Inguinal region is a single anatomic basin, even if bilateral)
⚠️ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| ❌ | CODING SYMPTOMS WITH DEFINITIVE DIAGNOSIS. Assigning R59.0 when the final pathology or discharge summary confirms a definitive cause (e.g., lymphoma, metastatic cancer) for which the lymphadenopathy is a routine manifestation. |
| ❌ | DEFAULTING TO UNSPECIFIED. Using R59.9 when the physical exam or radiology report clearly describes the enlargement as confined to a single regional basin. |
| ✅ | QUERY FOR CLARITY. If the provider documents “lymphadenopathy” without specifying localized or generalized, review the H&P and imaging. If only one basin is involved, query the provider to specify “localized” to support R59.0. |
| ✅ | LINK TO ETIOLOGY. If the localized lymphadenopathy is due to a specific localized infection (e.g., cat scratch disease A28.1), code the infection first. |
| ✅ | BILATERAL SAME REGION. Bilateral involvement of the same anatomic region (e.g., bilateral cervical or bilateral inguinal) is still considered “localized” for coding purposes under R59.0, as it does not cross into multiple non-contiguous basins. |
📚 Sources
1 CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2026. 2 American College of Hematology (ASH). Clinical Guidelines for the Evaluation of Lymphadenopathy. 3 Ferrer, R. (1998). Lymphadenopathy: Differential Diagnosis and Evaluation. American Family Physician, 58(6), 1313-1320. (Source for clinical size criteria and evaluation algorithms.) 4 CMS. IPPS Final Rule FY2026 — MS-DRG Definitions Manual v43. MDC 16 logic tables. 5 AMA. CPT Professional Edition 2026. Surgery / Lymphatic System subsection.